Rask Invest Research Team

The Rask Invest research team produces daily ASX news and research on ASX-listed companies and funds. Join the conversation inside the free investor community. Click here to have your say.

99% of long-term investing is doing nothing; the other 1% changes your life

Rask Invest Research Team's latest insights

Today's ASX news

A deep dive into PME shares

Is the Pro Medicus Limited (ASX:PME) share price undervalued? Here are 3 reasons you might want to consider PME shares.

Today's ASX news

How to value RMD and FLT shares

The Resmed CDI (ASX:RMD) share price is down around 4.3% since the start of 2025. It’s probably worth asking, ‘is the RMD share price top value?’

Today's ASX news

I’m watching the SHL share price in 2025

The Sonic Healthcare Ltd (ASX:SHL) share price is down around 6.3% since the start of 2025. It’s probably worth asking, ‘is the SHL share price priced to perfection?’

Today's ASX news

PLS and NWL shares: why you should take notice

The Pilbara Minerals Ltd (ASX:PLS) share price has decreased 14.9% since the start of 2025. It’s probably worth asking, ‘is the PLS share price good value?’

Better investing starts here.

Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best  insights.

Skip to content